Mia Crous

Dr. Mia Crous


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2025 in Pathogens
Verified
Journal Article
Open access
PDF file
MCMia Crous
Mia Crous
AHAllison Hempenstall
Allison Hempenstall
NLNancy Lui-Gamia
Nancy Lui-Gamia
CTCaroline Taunton
Caroline Taunton
JHJosh Hanson
Josh Hanson
We used the Queensland acute rheumatic fever (ARF) and rheumatic heart disease (RHD) register to describe the clinical phenotype and the characteristics of individuals diagnosed with ARF in Far North Queensland, Australia, between January 2012 and December 2023. There were 830 episodes of ARF in 740 individuals during the study period; 785/830 (95%) episodes occurred in First Nations Australians and 696/824 occurred in areas of socioeconomic disadvantage. There was no significant change in the overall incidence of ARF during the study period (Spearman’s rho = 0.51, p = 0.09). The median (interquartile range) age of the cohort was 15 (10–23) years, although 276/830 (33%) episodes of ARF occurred in individuals ≥ 20 years. Individuals with carditis, polyarthritis, an abnormal electrocardiogram, fever and elevated inflammatory markers were more likely to have confirmed ARF. The presence of polyarthralgia, monoarthritis or skin manifestations was not associated with a diagnosis of confirmed ARF. Individuals with monoarthralgia were less likely to have confirmed ARF. At the end of the study period, 264/706 (37%) individuals who had access to echocardiography had confirmed RHD. Individuals who did not have echocardiography documented as a component of their initial episode of care were more likely to have severe RHD at the end of the study (25/339 (7%) versus 7/401 (2%), p < 0.0001). ARF and RHD continue to be diagnosed in First Nations Australians in tropical Australia. It seems unlikely that Australia will achieve its stated aim of eliminating RHD by 2031.

31 March 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
MCMia Crous
Mia Crous
AHAllison Hempenstall
Allison Hempenstall
NLNancy Lui-Gamia
Nancy Lui-Gamia
CTCaroline Taunton
Caroline Taunton
JHJosh Hanson
Josh Hanson
We used the Queensland acute rheumatic fever (ARF) and rheumatic heart disease (RHD) register to describe the clinical phenotype and the characteristics of consecutive individuals diagnosed with ARF in Far North Queensland, tropical Australia between January 2012 and December 2023. There were 830 episodes of ARF in 740 individuals during the study period; 785/830 (95%) episodes occurred in First Nations Australians and 696/824 (84%) occurred in areas of socioeconomic disadvantage. There was no significant change in overall incidence of ARF during the study period (rs=0.51, p=0.09). The median (interquartile range) age of the cohort was 15 (10-23) years, although 276/830 (33%) episodes occurred in individuals ≥20 years. Individuals with carditis, polyarthritis, an abnormal electrocardiogram, fever and elevated inflammatory markers were more likely to have confirmed ARF. The presence of polyarthralgia, monoarthritis and the skin manifestations of ARF was not associated with a diagnosis of confirmed ARF. Individuals with monoarthralgia were less likely to have confirmed ARF. At the end of the study period 266/706 (38%) of individuals who had access to echocardiography had confirmed RHD. Individuals who did not have documented echocardiography as a component of their episode of care were more likely have severe RHD at the end of the study (25/339 (7%) versus 7/401 (2%), p< 0.0001). ARF and RHD continue to be diagnosed in First Nations Australians in tropical Australia. It seems unlikely that the country will achieve its stated aim of eliminating RHD by 2031.